SEC 13F Intelligence

Parallel Advisors, LLC / ABBV

Parallel Advisors, LLC’s Abbvie Inc Position

Does Parallel Advisors, LLC own Abbvie Inc (ABBV)? Yes — 103.9K shares worth $23M (+0.41% of its 13F portfolio) as of Q2 2026.

Position Value
$23M
Q2 2026
Shares
103.9K
% of Portfolio
+0.41%
Quarters Held
31
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $2MQ2 ’19: $2MQ3 ’19: $2MQ4 ’19: $2MQ4 ’19Q1 ’20: $2MQ2 ’20: $2MQ3 ’20: $2MQ4 ’20: $3MQ4 ’20Q1 ’21: $3MQ2 ’21: $3MQ3 ’21: $3MQ4 ’21: $4MQ4 ’21Q1 ’22: $5MQ2 ’22: $5MQ3 ’22: $4MQ4 ’22: $6MQ4 ’22Q1 ’23: $18MQ2 ’23: $15MQ3 ’23: $17MQ4 ’23: $17MQ4 ’23Q1 ’24: $17MQ2 ’24: $19MQ3 ’24: $21MQ4 ’24: $19MQ4 ’24Q1 ’25: $22MQ2 ’25: $19MQ3 ’25: $24MQ4 ’25: $23MQ4 ’25Q1 ’26: $23MQ2 ’26: $23Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2026103.9K$23M+0.41%
Q1 2026103.9K$23M+0.41%
Q4 2025102.6K$23M+0.43%
Q3 2025105.2K$24M+0.45%
Q2 2025104.6K$19M+0.39%
Q1 2025107.0K$22M+0.51%
Q4 2024108.2K$19M+0.43%
Q3 2024108.8K$21M+0.51%
Q2 2024110.1K$19M+0.48%
Q1 2024112.2K$17M+0.56%
Q4 2023110.4K$17M+0.51%
Q3 2023112.2K$17M+0.56%
Q2 2023110.5K$15M+0.48%
Q1 2023111.8K$18M+0.60%
Q4 202236.7K$6M+0.26%
Q3 202233.4K$4M+0.21%
Q2 202230.9K$5M+0.22%
Q1 202231.3K$5M+0.20%
Q4 202131.6K$4M+0.16%
Q3 202128.3K$3M+0.12%
Q2 202128.2K$3M+0.13%
Q1 202125.0K$3M+0.13%
Q4 202023.7K$3M+0.14%
Q3 202025.3K$2M+0.14%
Q2 202024.5K$2M+0.16%
Q1 202022.6K$2M+0.14%
Q4 201922.6K$2M+0.15%
Q3 201922.5K$2M+0.15%
Q2 201928.9K$2M+0.21%
Q1 201925.7K$2M+0.23%
Q4 201826.2K$2M+0.34%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Parallel Advisors, LLC’s full portfolio or all institutional holders of ABBV.